NCT02974647 2026-04-22Study of Ruxolitinib in Relapsed or Refractory T or NK Cell LymphomaMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting83 enrolled
NCT05010005 2026-04-09A Study of Ruxolitinib and Duvelisib in People With LymphomaMemorial Sloan Kettering Cancer CenterPhase 1 Recruiting70 enrolled